The researchers have demonstrated that by measuring the levels of these markers, not only can an accurate diagnosis of cancer be made, but the stage the cancer has reached – whether it is still localized or already has spread and become metastatic – can be identified.
In addition, certain markers, if switched on, will hopefully give information on how quickly the cancer will develop, and, therefore, when treatment must be introduced.
The current, most widely used method of detecting prostate cancer is the serum Prostate Specific Antigen (PSA) test, which is only 50 per cent accurate. Increased levels of PSA are elevated in non-malignant conditions, such as benign prostatic hyperplasia, prostatitis and even urinary tract infections. This new test, which is able to detect one prostate cancer cell among a sample of 100 million blood cells, is 95 per cent accurate.
Because of its inaccuracy, most elevated serum PSA results are followed up. This is done using a core needle biopsy. Samples of tissue are removed by inserting a needle through the wall of the rectum into the prostate gland. When pulled out, the needles remove a cylinder of tissue, usually about 1/2-inch long and 1/16-inch across. Up to 12 needles are normally used to ensure the prostate is thoroughly sampled.
After this invasive procedure, tissue samples are sent to a laboratory for analysis, often taking a week or so for results to be confirmed.
Owing to a high serum PSA, some men will invariably have a biopsy in which the result will been negative for prostate cancer. It is hoped that the new test, with its increased accuracy, will encourage men who suspect they have prostate problems to seek medical attention early on, enabling early treatment and leading, hopefully, to less men having prostate biopsies.
The research has been partly funded by Prostate Research Campaign UK. Brigadier John Anderson, Chief Executive of the charity says: “Many men fear seeking medical help, even when they suspect they have prostate problems, for fear that the diagnosis will involve painful and undignified tests. This simple, speedy, non-invasive test means patients need not fear traumatic tests to diagnose prostate cancer. And receiving an accurate diagnosis within days rather than weeks could mean they are treated more quickly and stand a greater chance of total recovery.”
The research has also been funded by the Everard and Mina Goodman Charitable Foundation.
The test is currently at the stage of validation, with further development regarding standardisation and formatting, and could be introduced on to the market next year.
Prostate cancer is increasingly recognised as a major health problem in the UK, being the most commonly diagnosed solid cancer and the most common cause of cancer-related deaths in men. Around 27,000 new cases are diagnosed in the UK each year and there are around 10,000 deaths from prostate cancer each year around the world.
‘Farming’ bacteria to boost growth in the oceans
24.10.2016 | Max-Planck-Institut für marine Mikrobiologie
Calcium Induces Chronic Lung Infections
24.10.2016 | Universität Basel
Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion
Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
24.10.2016 | Earth Sciences
24.10.2016 | Life Sciences
24.10.2016 | Physics and Astronomy